Russell Kevin Klass bought $11k of ZOMDF
Sr. Vice President, Sales at Zomedica Corp.. 104,000 shares at an average of $0.10, traded May 21, 2026, filed May 26, 2026.
Score components
- +15RoleOfficer
- 0Trade size$11k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +8Price context32% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- +5Repeat buying2 buys in 90 days
- +5Track recordMedian 6-month excess return +7% over 8 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001654954-26-005315, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 21, 2026 | POpen-market purchase Common Stock, without par valueindirect: spouse | +104,000 | $0.10 | $11k | 104,000 | May 26, 2026 |
Related signals
Other insiders at Zomedica Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | Zomedica Corp. | Russell Kevin Klass Vice President of Sales | $23k 216,899 shares | +4% | |
| 43Moderate | Zomedica Corp. | Johnny D Powers director | $21k 200,000 shares | +5% | |
| 51Moderate | Zomedica Corp. | Johnny D Powers director | $32k 300,000 shares | +8% | |
| 44Moderate | Zomedica Corp. | Johnny D Powers director | $56k 500,000 shares | +15% | |
| 55Moderate | Zomedica Corp. | Larry C Heaton II CEO | $28k 250,000 shares | +25% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $15k 150,000 shares | +3% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $12k 120,000 shares | +2% | |
| 23Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $475 5,000 shares | +0% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $20k 253,007 shares | +5% | |
| 40Moderate | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $42k 1,056,064 shares | +25% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.